Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders
Clinical trial NCT05154734 · COMPLETED
Trial details
- NCT number
- NCT05154734
- Sponsor
- Tianjin Medical University General Hospital
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-12
- Primary completion
- 2023-06-30
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.